Search - tctmd.com

Displaying 201 - 220 of 778

Sort: Relevancy | Date

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Daily News

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Caitlin E. Cox

August 25, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

News Daily News

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Caitlin E. Cox

July 12, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Featured Fellow

Ankur Kalra, MD

Yael L. Maxwell

May 26, 2017

Advertisement

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

SELUTION™ First-in-Man Study Achieves Primary Endpoint

CrossBoss First Shows Promise for Antegrade CTO PCI

Off Script: Focusing on the Future

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Ankur Kalra, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content